Afatinib CAS 439081-18-2 Purity > 99.5% (HPLC) Hoobkas

Lus piav qhia luv luv:

Lub npe tshuaj: Afatinib

Synonyms: BIBW2992

CAS: 439081-18-2 Nr

Purity:> 99.5% (HPLC)

Cov tsos mob: Off-White Powder

E-Mail: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chemical Properties:

Tshuaj npe Afatinib
Synonyms PAB 2992;BIBW-2992;BIBW2992 Dawb Base;Tomtovok;(S,E)-N-(4-(3-Chloro-4-Fluorophenylamino)-7-(Tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(Dimethylamino)tab sis-2-Enamide
CAS Nr 439081-18-2
CAT Number Qauv TSIS MUAJ: RF-PI2033
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C24H25ClFN5O3
Molecular Luj 485.94 ib
Solubility Soluble hauv DMSO
Qhov ntom 1.380 Nws
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Off-White hmoov
Kev txheeb xyuas HPLC, NMR
Purity / Analysis Method > 99.5% (HPLC)
Melting Point 100.0 ~ 102.0 ℃
Poob rau ziab <0.50%
Residue ntawm Ignition <0.20%
Tag nrho cov impurities <0.50%
Hnyav Hlau ≤ 20ppm
NMR Spectrum Raws li tus qauv
Test Standard Enterprise Standard
Txee lub neej 24 Lub Hlis yog khaws cia kom raug
Kev siv API;Afatinib;Afatinib Dimaleate;NSCLC

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo

Qhov zoo:

1

FAQ:

Daim ntawv thov:

Afatinib, tseem hu ua BIW-2992, (CAS: 439081-18-2) yog lub thib ob-tiam muaj zog thiab irreversible dual inhibitor ntawm epidermal loj hlob yam receptor (EGFR) thiab human epidermal growth factor receptor 2 (HER2) tyrosine kinase, tsim los ntawm Boehringer Ingelheim, lub teb chaws Yelemees.Nws muaj peev xwm ntawm irreversibly inhibiting kev ua ntawm tyrosine kinase los ntawm kev mus rau Michael cov tshuaj tiv thaiv nrog thiol pawg ntawm cysteine ​​​​ntawm txoj hauj lwm 797 ntawm EGFR.Thaum Lub Xya Hli 12, 2013, nws tau dhau los ua cov tshuaj tshiab rau kev tiv thaiv kab mob ntsws me me uas tau pom zoo los ntawm US FDA raws li lub npe lag luam ntawm Gilotrif.Cov tshuaj no yog ib ntsiav tshuaj.Nws yog siv rau kev kho mob ntawm cov neeg mob uas kuaj pom muaj metastatic tsis-me me ntsws qog nqaij hlav cancer (NSCLC) nrog kev poob ntawm 19th exon los yog L858R kev hloov hauv 21th exon ntawm cov qog epidermal loj hlob receptor (EGFR) paub tseeb tias siv cov khoom siv pom zoo. los ntawm FDA.Cov tshuaj kuj tseem siv tau zoo hauv kev kho mob HER2-zoo cov neeg mob uas mob qog noj ntshav siab.Afatinib belongs rau ib chav kawm ntawm cov tshuaj hu ua tyrosine kinase inhibitors.Tyrosine kinase inhibitors yog tsim los thaiv qhov kev ua ntawm ib qho enzyme hu ua tyrosine kinase.Cov enzyme no ua lub luag haujlwm loj hauv kev ua haujlwm ntawm cov hlwb, thiab ua haujlwm hauv kev txhawb nqa cov qog loj hlob thiab kev loj hlob.Afatinib ua haujlwm los tiv thaiv kev ua haujlwm ntawm ob hom tyrosine kinases: epidermal growth factor receptor (EGFR) thiab Her2, uas yog "tshaj tawm" los ntawm ntau hom mob qog noj ntshav.Los ntawm thaiv kev ua haujlwm ntawm cov tyrosine kinases, Afatinib tuaj yeem tiv thaiv cov qog nqaij hlav cancer ntawm kev faib thiab loj hlob.

Sau koj cov lus ntawm no thiab xa tuaj rau peb